市場調查報告書
商品編碼
1245642
輸尿管鏡全球市場規模、份額、行業趨勢分析報告:按最終用戶(醫院、門診手術中心等)、按產品(柔性、半剛性)、按應用、按地區展望和預測,2022-2028 年Global Ureteroscopy Market Size, Share & Industry Trends Analysis Report By End User (Hospitals, Ambulatory Surgical Centers, and Others), By Product (Flexible, and Semi- Rigid), By Application, By Regional Outlook and Forecast, 2022 - 2028 |
到 2028 年,輸尿管鏡的全球市場規模預計將達到 11 億美元,預測期內復合年增長率為 5.2%。
手術通常需要 1-3 小時,並且在患者處於全身麻醉下進行。 小結石通常可以通過將它們放入籃子裝置中來完全從輸尿管中取出。 如果結石較大或輸尿管直徑較小,通常必須用激光將結石打碎。 石頭被粉碎成小塊,碎片被移除。 通過輸尿管鏡可能會擴大輸尿管。 可能需要將一根稱為輸尿管支架的小管暫時留在輸尿管中,以便腎臟更有效地排出尿液。
COVID-19 影響分析
COVID-19 大流行引發了許多最終用戶行業的供應鏈,包括工業、醫療保健和醫療設備。 此外,由於大流行導致泌尿外科醫院就診率下降以及泌尿外科醫院的減少可能會限制輸尿管鏡設備的使用並抑制市場擴張。 此外,由於封鎖對泌尿外科的影響將減少對輸尿管鏡的需求,這也將抑制市場擴張。 由於 COVID-19 大流行,人們正在放棄擇期手術。 由於病毒感染的高風險,腎結石的治療也被推遲了很長時間。 在新興國家,先進輸尿管鏡技術的銷售預計將保持極其強勁。
市場增長因素
世界上老齡化人口的增長
根據世界衛生組織 (WHO) 的數據,到 2030 年,世界上將有六分之一的人超過 60 歲。 屆時,60歲及以上人口將從2020年的10億增長到14億。 此外,據說到2050年,600人以上的比例將翻一番。 從 2020 年到 2050 年,80 歲及以上的人口數量預計將增加兩倍,達到 4.26 億。 “老齡化”,即人口分佈的老齡化,始於高收入國家,但目前變化最大的是中低收入國家。 因此,預計在預測期內對輸尿管鏡的需求將會增加。
微創手術的增加
微創手術遠沒有傳統的開放手術那麼可怕。 使用傳統腹腔鏡器械進行的手術可能很困難且令人沮喪。 整個過程都使用專門的緊湊型設備,並通過較小的切口插入微創手術相機。 接受微創手術的患者恢復得更快,不適感也更少。 微創手術越來越受歡迎,因為它需要更短的住院時間、更精確、留下更少的疤痕、更少的痛苦並且需要更小的切口。
市場約束
輸尿管鏡檢查的潛在副作用
支架疼痛是輸尿管鏡檢查後最常見的風險或主訴,許多在輸尿管鏡檢查過程中放置了支架的患者都會出現疼痛。 支架是一種柔性塑料管,即使存在水腫或梗阻,也可以從腎臟引流至膀胱。 它大約是靜脈注射管的一半大小。 支架不僅在你小便時將尿液從膀胱推向腎臟,它還可以“摩擦”膀胱內部,引起尿意和類似於膀胱過度活動症的情況。 因此,可能會出現腋窩發熱、刺痛和劇烈疼痛等症狀。
產品概覽
根據產品,輸尿管鏡市場分為柔性和半剛性。 2021 年,半剛性部分在輸尿管鏡市場中佔據相當大的收入份額。 半剛性輸尿管鏡是一種用於觀察泌□□尿道內部的儀器。 輸尿管鏡用於觀察輸尿管內部,輸尿管是將尿液從腎臟輸送到膀胱的管道,比膀胱鏡更長更窄。 此外,輸尿管中的結石可以用半剛性輸尿管鏡觀察、破碎並由醫生取出。 因此,使用半剛性觀察泌尿道內部有望促進該段的擴張以及其他優勢。
使用展望
根據應用,輸尿管鏡市場分為尿石症、腎癌、尿路狹窄等。 2021 年,尿石症領域在輸尿管鏡市場中的收入份額最大。 這是由於慢性腎髒病和腎結石的患病率越來越高,尤其是在成人中,以及對輸尿管鏡的需求不斷增加。 “尿石症”是指在泌尿道中形成的結石或結石。 泌尿系統(包括腎臟和輸尿管)以及膀胱和尿道發生鈣化的疾病。 這些因素將推動輸尿管鏡檢查的使用並推動這一領域的增長。
最終用戶視角
按最終用戶劃分,輸尿管鏡市場分為醫院、門診手術中心等。 2021 年的輸尿管鏡市場將由醫院部門主導。 貢獻包括採用技術改進的輸尿管鏡設備、裝備精良的基礎設施、增加的購買力和增加的患者入院率。 越來越多的患者更喜歡在知識淵博的醫生的監督下接受充分護理的醫院,這也推動了這一細分市場的增長。
區域展望
按地區分析了北美、歐洲、亞太地區和 LAMEA 的輸尿管鏡市場。 到 2021 年,北美地區將佔輸尿管鏡市場最大的收入份額。 由於最先進的輸尿管鏡的可用性,腎臟問題的頻率增加和腎臟疾病意識的提高預計將推動該地區的市場。 有利的報銷政策、患者意識和最先進設備的使用等其他因素也在推動市場增長。 該地區還推動了兒科結石病例上升的行業發展。
The Global Ureteroscopy Market size is expected to reach $1.1 billion by 2028, rising at a market growth of 5.2% CAGR during the forecast period.
A specific type of endoscope called a ureteroscope is rigid, flexible, or semi-flexible, with a camera and light source at one end. Endoscopes, known as ureteroscopes are used to see within the urinary tract and examine it. Particularly long and narrow, ureteroscopy can be placed into the urethra, into the bladder, and into the ureter. These endoscopes are used for visual inspections and tool-assisted ureter internal examinations.
Urinary strictures, kidney cancer, kidney stones, and upper urinary tract urothelial carcinoma can all be detected and treated using this method. Several varieties of ureteroscopic are available, including flexible, stiff, semi-rigid, single-use, and double-channel ureteroscopes. A small telescope called a ureteroscope is sent through the bladder and urethra and up the ureter to the spot where the stone is placed during ureteroscopy, a treatment used to treat kidney stones.
The surgery typically takes one to three hours and is usually done while the patient is under general anesthesia. Smaller stones can usually be removed whole from the ureter by being captured in a basket device. If the stone is huge or the ureter's diameter is small, it must then be broken apart, usually with a laser. The stone is divided into tiny bits before these fragments are removed. The ureter may enlarge as a result of the ureteroscope's passage. To ensure that the kidney drains urine effectively, it may be essential to temporarily leave a small tube known as a ureteral stent inside the ureter.
COVID-19 Impact Analysis
The COVID-19 pandemic caused supply chains in a number of end-user industries, including industrial, healthcare, and medical devices. Moreover, a decline in urology hospital visits and fewer urology hospitals throughout the pandemic may limit the use of ureteroscope devices and restrain market expansion. Also, the lockdown's impact on urological surgeries caused a reduction in the demand for ureteroscopes, which also restrained market expansion. Because of the COVID-19 pandemic, people have put off elective surgeries. Due to the serious risk of viral transmission, people have also put delayed treating kidney stones for a long. In addition, emerging countries are expected to experience extremely robust sales of advanced ureteroscope technology.
Market Growth Factors
Rising old aged population across the globe
According to World Health Organization; one in six people globally will be 60 or older by 2030. By this point, there will be 1.4 billion people over 60, up from 1 billion in 2020. The proportion of people above 600 will double itself by 2050. Between 2020 and 2050, the number of people 80 or older is projected to treble, reaching 426 million. Although population aging, or the movement in a country's population's distribution towards older ages, began in high-income nations, it is currently low- and middle-income nations that are going through the most significant transformation. This will drive up demand for ureteroscopy during the anticipated period.
Rising number of less invasive surgeries
Minimally invasive surgeries are considerably less dreadful than conventional open surgeries. Traditional operations performed with traditional laparoscopic tools can be challenging and upsetting. Specialized, compact equipment is used throughout the process, and minimally invasive surgical cameras are inserted through smaller incisions. Patients who undergo minimally invasive procedures recover more rapidly and with less discomfort. Minimally invasive surgical procedures are gaining popularity because they need fewer hospital stays, are more precise, leave fewer scars, are less painful, and require smaller incisions.
Market Restraining Factors
Possible side effects of ureteroscopes
Stent pain is the most prevalent risk or complaint after ureteroscopy, occurring in many patients who had a stent placed during a ureteroscopy. A stent is a flexible plastic tube that permits the kidney to drain to the bladder despite edema or occlusion. It is around half the size of IV tubings. In addition to allowing urine to pass up from the bladder to the kidney during urination, the stent can "rub" on the inside of the bladder, giving the sensation of needing to urinate or having an overactive bladder. This can result in symptoms ranging from a warm, tingling sensation to severe pain in the affected flank.
Product Outlook
Based on product, the ureteroscopy market is segmented into flexible and semi- rigid. In 2021, the semi-rigid segment covered a considerable revenue share in the urethroscopy market. A semi-rigid ureteroscope is an instrument used to view the interior of the urinary tract. A ureteroscope is used to see into the ureters, the tubes that convey urine from the kidneys to the bladder, which are longer and thinner than the cystoscope. Moreover, a stone in the ureter can be seen, fragmented, and removed by the doctor using a semi-rigid ureteroscope. Thus, using semi-rigid to look within the urinary tract, along with other advantages, is anticipated to drive the segment's expansion.
Application Outlook
On the basis of application, the ureteroscopy market is divided into urolithiasis, kidney cancer, urinary stricture and others. In 2021, the urolithiasis segment witnessed the largest revenue share in the ureteroscopy market. This is due to the elevated prevalence of chronic kidney disorders and kidney stone development, particularly in adults, raising the demand for ureteroscopes. "Urolithiasis" refers to calculi or stones that develop in the urinary tract. The urinary system, primarily the kidneys or ureters but often the bladder and/or urethra, develop calcifications due to this illness. These elements will boost ureteroscopy utilization and fuel the segment's growth.
End User Outlook
By end user, the ureteroscopy market is classified into hospitals, ambulatory surgical centers, and others. The hospital segment dominated the ureteroscopy market with the maximum revenue share in 2021. The adoption of technologically improved ureteroscope devices, a well-equipped infrastructure, increased purchasing power, and an increase in patient admission all contribute to this. Also, a rise in patients' preference for hospitals, which properly administer treatments under the supervision of knowledgeable doctors, is another factor driving the segment's expansion.
Regional Outlook
Region-wise, the ureteroscopy market is analyzed across North America, Europe, Asia Pacific, and LAMEA. In 2021, the North America region generated the maximum revenue share in the ureteroscopy market. The availability of cutting-edge ureteroscopes increased frequency of kidney problems, and increased awareness of renal diseases are projected to propel the market in the region. The market is also growing due to other factors like advantageous reimbursement policies, patient consciousness, and the use of cutting-edge instruments. The industry is also driven by increased pediatric stone cases in the area.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Boston Scientific Corporation, Olympus Corporation, Hoya Corporation, Steris PLC, Stryker Corporation, Advin Health Care, Karl Storz SE & Co. KG, Richard Wolf GmbH, Cliniva Healthcare, and OTU Medical Inc.
Market Segments covered in the Report:
By End User
By Product
By Application
By Geography
Companies Profiled
Unique Offerings from KBV Research
List of Figures